CORC

浏览/检索结果: 共5条,第1-5条 帮助

已选(0)清除 条数/页:   排序方式:
GLP-1 receptor agonist lixisenatide protects against high free fatty acids-induced oxidative stress and inflammatory response 期刊论文
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 卷号: 47, 期号: 1
作者:  Zhao, Qini;  Xu, Haiming;  Zhang, Lirong;  Liu, Long;  Wang, Libo
收藏  |  浏览/下载:27/0  |  提交时间:2019/12/05
Sustained Release Strategy Designed for Lixisenatide Delivery to Synchronously Treat Diabetes and Associated Complications 期刊论文
ACS APPLIED MATERIALS & INTERFACES, 2019, 卷号: 11, 期号: 33
作者:  Zhuang, Yaping;  Yang, Xiaowei;  Li, Yamin;  Chen, Yipei;  Peng, Xiaochun
收藏  |  浏览/下载:18/0  |  提交时间:2019/12/05
Lixisenatide:治疗2型糖尿病的新药 期刊论文
实用药物与临床, 2018, 卷号: 21, 期号: 7
作者:  王婷婷;  刘敏;  张玉;  周微
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Lixisenatide:治疗2型糖尿病的新药 期刊论文
实用药物与临床, 2018, 卷号: 21, 期号: 7
作者:  王婷婷;  刘敏;  张玉;  周微
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double‐blind, placebo‐controlled, 24‐week trial (GetGoal‐M‐Asia) 期刊论文
Diabetes/Metabolism Research and Reviews, 2014, 卷号: 30, 期号: 8, 页码: 726-735
作者:  Pan, Chang Yu*;  Han, Ping;  Liu, Xiaoming;  Yan, Shengli;  Feng, Ping
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/03


©版权所有 ©2017 CSpace - Powered by CSpace